By Richard Vanderford ( September 23, 2013, 7:08 PM EDT) -- Impax Laboratories Inc. and other drug makers said Monday that generic versions of Purdue Pharma LP's OxyContin do not infringe Purdue-held patents, opening a patent trial that could help end Purdue's monopoly on some formulations of the popular painkiller....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.